A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years

被引：8

作者：

Patruno, Cataldo ^{[1
]}

Fabbrocini, Gabriella ^{[2
]}

Lauletta, Giuseppe ^{[2
]}

Boccaletti, Valeria ^{[3
]}

Colonna, Cristiana ^{[4
]}

Cavalli, Riccardo ^{[4
]}

Neri, Iria ^{[5
]}

Ortoncelli, Michela ^{[6
]}

Schena, Donatella ^{[7
]}

Stingeni, Luca ^{[8
]}

Hansel, Katharina ^{[8
]}

Piccolo, Vincenzo ^{[9
]}

Di Brizzi, Veronica ^{[9
]}

Potenza, Concetta ^{[10
]}

Tolino, Ersilia ^{[10
]}

Bianchi, Luca ^{[11
]}

Manti, Sara ^{[11
]}

De Pasquale, Rocco ^{[12
]}

Di Lernia, Vito ^{[13
]}

Caminiti, Lucia ^{[14
]}

Galli, Elena ^{[15
]}

Coppo, Paola ^{[16
]}

Chiricozzi, Andrea ^{[17
,18
]}

De Simone, Clara ^{[17
,18
]}

Guerriero, Cristina ^{[17
]}

Amoruso, Fabrizio Giuseppe ^{[19
]}

Provenzano, Eugenio ^{[19
]}

Leonardi, Salvatore ^{[20
]}

Licari, Amelia ^{[21
]}

Marseglia, Gian Luigi ^{[21
]}

Palermo, Antonino ^{[22
]}

Di Pillo, Sabrina ^{[23
]}

Russo, Daniele ^{[23
]}

Moschese, Viviana ^{[24
]}

Patella, Vincenzo ^{[25
]}

Peduto, Tiziana ^{[25
]}

Ferreli, Caterina ^{[26
]}

Zangari, Paola ^{[27
]}

Veronese, Federica ^{[28
]}

Berti, Samantha Federica ^{[29
]}

Gruber, Michaela ^{[30
]}

Pezzolo, Elena ^{[31
]}

Termine, Stefania ^{[32
]}

Satta, Rosanna ^{[33
]}

Dragoni, Federica ^{[34
]}

Esposito, Maria ^{[35
]}

Fargnoli, Maria Concetta ^{[35
]}

Chiodini, Paolo ^{[9
]}

Vallone, Ylenia ^{[2
]}

di Vico, Francesca ^{[2
]}

机构：

[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy

[2] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy

[3] Univ Brescia, Dept Med, Sect Dermatol, Brescia, Italy

[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Clin Sci & Community Hlth, Pediat Dermatol Unit, Milan, Italy

[5] Univ Bologna, Unit Dermatol, IRCCS AOU Policlin S Orsola, Bologna, Italy

[6] Univ Turin, Dept Med Sci, Div Dermatol, Turin, Italy

[7] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy

[8] Univ Perugia, Dept Med & Surg, Dermatol Sect, Perugia, Italy

[9] Univ Campania Luigi Vanvitelli, Dermatol Unit, Caserta, Italy

[10] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Dermatol Unit Daniele Innocenzi, Polo Pontino, Latina, Italy

[11] Univ Tor Vergata, Syst Med Dept, Dermatol Unit, Policlin Tor Vergata, Rome, Italy

[12] Osped San Marco, UO Dermatol, Catania, Italy

[13] Azienda USL IRCCS Reggio Emilia, Dermatol Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy

[14] Univ Messina, Policlin Hosp, Messina, Italy

[15] Osped San Pietro Fatebenefratelli, UOS Immuno Allergol Eta evolut, Rome, Italy

[16] Regina Margher Childrens Hosp Citta Salute & Sci T, Pediat Endocrinol Unit, Turin, Italy

[17] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, Dermatol, Rome, Italy

[18] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslazionale, Dermatol, Rome, Italy

[19] Azienda Osped Cosenza, Dermatol Unit, Cosenza, Italy

[20] Univ Catania, San Marco Hosp, Dept Clin & Expt Med, Pediat Resp Unit, Catania, Italy

[21] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Pediat, Pediat Clin, Pavia, Italy

[22] Garibaldi Hosp, Dept Pediat, Catania, Italy

[23] Univ G dAnnunzio, Dept Pediat, Pediat Allergy & Pulmonol Unit, Chieti, Italy

[24] Univ Roma Tor Vergata, Pediat Allergol & Immunol Unit, Policlin Tor Vergata, Rome, Italy

[25] Santa Maria Speranza Hosp, Dept Med, Div Allergy & Clin Immunol, Battipaglia, SA, Italy

[26] Univ Cagliari, Dept Med Sci & Publ Hlth, Dermatol Clin, Cagliari, Italy

[27] Bambino Gesu Pediat Hosp, Acad Dept Pediat DPUO, Res Unit Clin Immunol & Vaccinol, IRCCS, Rome, Italy

[28] AOU Maggiore Car Hosp, Dermatol Clin, Novara, Italy

[29] Univ Florence, Dept Surg & Translat Med, Dermatol Unit, Florence, Italy

[30] Cent Hosp Bolzano, Dept Pediat, Bolzano, Italy

[31] Osped San Bortolo, Dermatol Unit, Vicenza, Italy

[32] Santa Chiara Hosp, Div Dermatol, Trento, Italy

[33] Univ Sassari, Dipartimento Sci Med Chirurg & Sperimentali, Sassari, Italy

[34] UOC Dermatol Osped San Donato, Arezzo, Italy

[35] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Dermatol, Laquila, Italy

来源：

JOURNAL OF DERMATOLOGICAL TREATMENT | 2023年 / 34卷 / 01期

关键词：

Atopic dermatitis; children; dupilumab; real-world data;

D O I：

10.1080/09546634.2023.2246602

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background: Dupilumab has been shown to be a safe and effective drug for the treatment of atopic dermatitis (AD) in children from 6 months to 11 years in randomized clinical trials. Aim: The aim of this real-life study was to determine the effectiveness in disease control and safety of dupilumab at W52 in moderate-to-severe AD children aged 6-11 years. Methods: All data were collected from 36 Italian dermatological or paediatric referral centres. Dupilumab was administered at label dosage with an induction dose of 300 mg on day 1 (D1), followed by 300 mg on D15 and 300 mg every 4 weeks (Q4W). Treatment effect was determined as overall disease severity, using EASI, P-NRS, S-NRS and c-DLQI at baseline, W16, W24, and W52. Ninety-six AD children diagnosed with moderate-to-severe AD and treated with dupilumab were enrolled. Results: Ninety-one (94.8%) patients completed the 52-week treatment period and were included in the study. A significant improvement in EASI score, P-NRS, S-NRS and c-DLQI was observed from baseline to weeks 16, 24 and 52. Conclusions: Our real-life data seem to confirm dupilumab effectiveness and safety in paediatric patients. Moreover, our experience highlighted that patients achieving clinical improvement at W16 preserved this condition over time.

引用

页数：6

共 50 条

[41] Efficacy and safety of dupilumab in pediatric patients with moderate to severe atopic dermatitis: a real-world study
Yang, Dan-Yang
Li, Li
Lu, Tao
Jing, Wen-Wen
Liu, Xin
Li, Xiao-Li
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (03) : 467 - 472
[42] Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study
Megna, Matteo
Di Costanzo, Luisa
Argenziano, Giuseppe
Balato, Anna
Colasanti, Paola
Cusano, Francesco
Galluccio, Antonia G.
Gambardella, Alessio
Lembo, Serena
Mozzillo, Raffaele
Di Luzio, Genoveffa Scotto
Fabbrocini, Gabriella
Balato, Nicola
EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 855 - 861
[43] Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis)
Gargiulo, Luigi
Ibba, Luciano
Alfano, Angela
Malagoli, Piergiorgio
Amoruso, Fabrizio
Balato, Anna
Barei, Francesca
Burroni, Anna G.
Caccavale, Stefano
Calzavara-Pinton, Piergiacomo
Esposito, Maria
Fargnoli, Maria C.
Ferrucci, Silvia M.
Foti, Caterina
Girolomoni, Giampiero
Gola, Massimo
Guanti, Mario B.
Gurioli, Carlotta
Magliulo, Manfredi
Maurelli, Martina
Morrone, Pietro
Musumeci, Maria L.
Napolitano, Maddalena
Ortoncelli, Michela
Patruno, Cataldo
Piraccini, Bianca M.
Pezzolo, Elena
Ribero, Simone
Rossi, Mariateresa
Savoia, Paola
Sciarrone, Claudio
Tirone, Benedetta
Vaccino, Marco
Veronese, Federica
Costanzo, Antonio
Narcisi, Alessandra
JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
[44] Real-World Efficacy and Safety of Dupilumab Use in Japanese Adult Patients with Atopic Dermatitis: A Single-Center, Retrospective, 104-Week, Observational Study
Ikegami, Tetsuharu
Igawa, Ken
DISEASES, 2025, 13 (02)
[45] Real-world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2-year experience
Fujiwara, Chisako
Uchiyama, Akihiko
Inoue, Yuta
Ishikawa, Mai
Motegi, Sei-ichiro
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 88 - 93
[46] Effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis: a preliminary report of real-world data
Ferrucci, Silvia M.
Maronese, Carlo A.
Tavecchio, Simona
Angileri, Luisa
Genovese, Giovanni
Marzano, V. Angelo
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2022, 157 (02) : 211 - 213
[47] One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study
Uchida, Hideaki
Kamata, Masahiro
Kato, Aika
Mizukawa, Itsumi
Watanabe, Ayu
Agematsu, Ai
Nagata, Mayumi
Fukaya, Saki
Hayashi, Kotaro
Fukuyasu, Atsuko
Tanaka, Takamitsu
Ishikawa, Takeko
Ohnishi, Takamitsu
Tada, Yayoi
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (02) : 547 - 550
[48] Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single-center retrospective study
Uchiyama, Akihiko
Fujiwara, Chisako
Inoue, Yuta
Motegi, Sei-ichiro
JOURNAL OF DERMATOLOGY, 2022, 49 (04): : 469 - 471
[49] Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort Study
Jo, Christine E.
Georgakopoulos, Jorge R.
Ladda, Matthew
Ighani, Arvin
Mufti, Asfandyar
Drucker, Aaron M.
Piguet, Vincent
Yeung, Jensen
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2020, 24 (05) : 468 - 473
[50] Real-world effectiveness and safety of upadacitinib in Japanese patients with atopic dermatitis: a two-centre retrospective study
Kosaka, Keiji
Uchiyama, Akihiko
Ishikawa, Mai
Watanabe, Goichi
Motegi, Sei-ichiro
EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (06) : 800 - 802

← 1 2 3 4 5 →